Results 211 to 220 of about 1,293,045 (377)

Hierarchical Superposition Framework Reveals the Complex Effects of Natural Medicine Formulas

Advanced Intelligent Systems, EarlyView.
A novel hierarchical superposition pharmacological model incorporates the principle of hierarchical structures from physics to simulate the spatiotemporal dynamics of drug combinations, to elucidate the universal law underlying drug combination effects. By modeling cross‐level causal transmission and attenuation, it advances beyond traditional additive
Weifeng Liang, Dingsi Xiang, Shengli Mi, Jiajun Huang   +3 more
wiley   +1 more source

Cost-effectiveness of low-dose colchicine in patients with chronic coronary disease in The Netherlands. [PDF]

Eur Heart J Qual Care Clin Outcomes
Fiolet ATL, Keusters W, Blokzijl J, Nidorf SM, Eikelboom JW, Budgeon CA, Tijssen JGP, Römer T, Westendorp I, Cornel JH, Thompson PL, Frederix GWJ, Mosterd A, de Wit GA.   +13 more
europepmc   +1 more source

Platelets and coronary disease [PDF]

BMJ, 1985
openaire   +3 more sources

Spatiotemporal Super‐Resolution Imaging of Lipid Metabolism Dynamics in Physiological/Pathological Conditions

Angewandte Chemie, EarlyView.
A novel polarity‐sensitive fluorescent probe was developed for the selective targeting of lipid droplets, enabling precise visualization and quantification of lipid metabolism disorders using an integrated STED‐FLIM platform. This probe allows accurate monitoring of lipid metabolism in cellular and pathological contexts, such as atherosclerosis ...
Shixian Cao, Qihang Ding, Caixia Sun, Borbala Codogno, Zhiqiang Liu, Xiaoqiang Yu, Jong Seung Kim, Kang‐Nan Wang   +7 more
wiley   +2 more sources

Associations between depression, resilience, and fatigue in patients with multivessel coronary disease: A cross-lag study. [PDF]

Int J Nurs Sci
Sun B, Han J, Tian B, Xu Y, Wang J, Wang J.   +5 more
europepmc   +1 more source

The etiology of cardiac enlargement in coronary occlusion, hypertension, and coronary artery disease

, 1954
Arthur M. Mastér
openalex   +1 more source

Cystatin C as Biomarker for the Evaluation of Renal Outcome in AL Amyloidosis

American Journal of Hematology, EarlyView.
ABSTRACT Cystatin C (CysC) has emerged as a novel and potentially more reliable biomarker for the estimation of glomerular filtration in the general population in patients with various conditions. In AL amyloidosis, the current renal staging system and renal response criteria are based on proteinuria and creatinine‐based eGFR.
Foteini Theodorakakou, Despina Fotiou, Filia Apostolakou, Ioannis Papassotiriou, Vasiliki Spiliopoulou, Ioannis Ntanasis‐Stathopoulos, Panagiotis Malandrakis, Magdalini Migkou, Nikolaos Kanellias, Evangelos Eleutherakis‐Papaiakovou, Erasmia Psimenou, Asimina Papanikolaou, Charikleia Gakiopoulou, Smaragdi Marinaki, Stavroula Giannouli, Maria Gavriatopoulou, Evangelos Terpos, Meletios‐Athanasios Dimopoulos, Efstathios Kastritis   +18 more
wiley   +1 more source

Nanoparticle‐Mediated Targeted Protein Degradation: An Emerging Therapeutics Technology

Angewandte Chemie, EarlyView.
Targeted protein degradation (TPD) has emerged as a powerful therapeutic approach, with numerous candidates molecules now advancing into clinical development. Recent innovations have incorporated nanoparticles to facilitate and enhance these degradation processes, yielding synergistic effects.
Andrew G. Baker, Adrian Pui Ting Ho, Laura S. Itzhaki, Ljiljana Fruk   +3 more
wiley   +2 more sources

In-stent neoatherosclerosis: a new problem or an opportunity to rethink the treatment of coronary disease? [PDF]

AsiaIntervention
Ussia GP, Cocco N.
europepmc   +1 more source

Simplified Approach to Predicting Obstructive Coronary Disease With Integration of Coronary Calcium: Development and External Validation. [PDF]

J Am Heart Assoc, 2023
Miller RJH, Gransar H, Rozanski A, Dey D, Al-Mallah M, Chow BJW, Kaufmann PA, Cademartiri F, Maffei E, Han D, Slomka PJ, Berman DS.   +11 more
europepmc   +1 more source